QUANTIVAC
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

QUANTIVAC Trademark

Serial Number: 79311221 • Registration: 6635213

QUANTIVAC is a trademark filed by EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG on January 29, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (54 trademarks)

SEEKAMP 31
LÜBECK D-23560 , DE

Entity Type: 03

Trademark Details

Filing Date

January 29, 2021

Registration Date

February 8, 2022

Published for Opposition

November 23, 2021

Goods & Services

Measuring, detecting and monitoring instruments, measuring, detecting and monitoring, devices, and measuring, detecting and monitoring regulators for preparing, processing and evaluating diagnostic samples for detecting allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases, food intolerances and cancer; Sensors and detectors, in particular UV fluorescence and chemiluminescence detectors for preparing, processing and evaluating diagnostic samples; Apparatus for recording, transmitting or reproducing diagnostic data, sound or images, in particular cameras, microscopes, photometers, microplate photometers, enzyme-linked immunosorbent assay readers, chemiluminescence readers, photomultipliers, microplate readers; Downloadable, recorded or preinstalled software, in particular downloadable, recorded or preinstalled laboratory software for analyzing laboratory test results

Diagnostic preparations, in particular diagnostic preparations for medical and veterinary purposes for the detection of allergies, neurological diseases, metabolic diseases, infectious diseases, autoimmune diseases, food intolerances, and cancer; diagnostic preparations for medical and veterinary purposes; diagnostic preparations for medical and veterinary purposes, in particular immobilised proteins, nucleic acids, allergens and tissue sections on a carrier/a carrier material, in particular a biochip, microsphere, test strip, blot, microtiter plate or membrane; reagents for medical and veterinary diagnostic purposes; reagents for medical and veterinary diagnosis, in particular immobilised proteins, nucleic acids, allergens and tissue, sections on a carrier/a carrier material, in particular a biochip, microsphere, paper ring, test strip, blot, microtiter plate or membrane

Diagnostic preparations and diagnostic substances for scientific purposes, in particular immobilised proteins, nucleic acids, allergens and tissue sections on a carrier/a carrier material, in particular a biochip, microsphere, paper ring, test strip, blot, microtiter plate or membrane

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 16, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jul 16, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Jul 16, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 8, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 8, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Dec 6, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 23, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 3, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 13, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 12, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 12, 2021 TROA
REFUSAL PROCESSED BY IB
Sep 11, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 23, 2021 RFCS
REFUSAL PROCESSED BY MPU
Aug 23, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 20, 2021 RFCR
NON-FINAL ACTION WRITTEN
Aug 19, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
May 25, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 21, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 20, 2021 REPR